A Phase 3 trial testing efgartigimod administered into a vein in adults with primary immune thrombocytopenia (ITP) is still enrolling participants and its top-line…
Immune thrombocytopenia
Whether you're newly diagnosed with ITP or have been managing it for some time, these resources offer guidance on symptoms, treatment options, and emotional support to help you move forward with confidence.
While there’s no cure for immune thrombocytopenia, a range of treatments — from steroids to platelet-boosting therapies — can help manage symptoms. Choosing the right plan depends on platelet levels, bleeding risk, and individual health considerations.
Latest news
Sobi’s Doptelet (avatrombopag), which is available as a tablet and an oral granule called Doptelet Sprinkle, is now approved in the U.S. for children…
